• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏钠氢交换体在健康和疾病中的调节。

Regulation of the cardiac Na⁺/H⁺ exchanger in health and disease.

机构信息

Department of Molecular Physiology, National Cerebral and Cardiovascular Center Research Institute, Fujishirodai 5-7-1, Suita, Osaka 565-8565, Japan.

出版信息

J Mol Cell Cardiol. 2013 Aug;61:68-76. doi: 10.1016/j.yjmcc.2013.02.007. Epub 2013 Feb 18.

DOI:10.1016/j.yjmcc.2013.02.007
PMID:23429007
Abstract

The Na(+) gradient produced across the cardiac sarcolemma by the ATP-dependent Na(+)-pump is a constant source of energy for Na(+)-dependent transporters. The plasma membrane Na(+)/H(+) exchanger (NHE) is one such secondary active transporter, regulating intracellular pH, Na(+) concentration, and cell volume. NHE1, the major isoform found in the heart, is activated in response to a variety of stimuli such as hormones and mechanical stress. This important characteristic of NHE1 is intimately linked to heart diseases, including maladaptive cardiac hypertrophy and subsequent heart failure, as well as acute ischemic-reperfusion injury. NHE1 activation results in elevation of pH and intracellular Na(+) concentration, which potentially enhance downstream signaling cascades in the myocardium. Therefore, in addition to determining the mechanism underlying regulation of NHE1 activity, it is important to understand how the ionic signal produced by NHE1 is transmitted to the downstream targets. Extensive studies have identified many accessory factors that interact with NHE1. Here, we have summarized the recent progress on understanding the molecular mechanism underlying NHE1 regulation and have shown a possible signaling pathway leading to cardiac remodeling, which is initiated from NHE1. This article is part of a Special Issue entitled "Na(+) Regulation in Cardiac Myocytes".

摘要

由 ATP 依赖的钠泵在心肌细胞膜上产生的 Na+梯度为 Na+依赖性转运蛋白提供了恒定的能量来源。质膜 Na+/H+交换器(NHE)就是这样一种次级主动转运蛋白,它可以调节细胞内 pH 值、Na+浓度和细胞体积。NHE1 是心脏中主要的同工酶,它可以响应多种刺激,如激素和机械应激而被激活。NHE1 的这一重要特性与心脏疾病密切相关,包括适应性心肌肥厚和随后的心力衰竭以及急性缺血再灌注损伤。NHE1 的激活导致 pH 值和细胞内 Na+浓度升高,这可能增强心肌中的下游信号级联反应。因此,除了确定 NHE1 活性调节的机制外,了解由 NHE1 产生的离子信号如何传递到下游靶标也很重要。大量研究已经确定了许多与 NHE1 相互作用的辅助因子。在这里,我们总结了近年来对 NHE1 调节的分子机制的理解,并展示了一条可能的信号通路,该通路从 NHE1 开始引发心脏重构。本文是题为“心肌细胞中的 Na+调节”的特刊的一部分。

相似文献

1
Regulation of the cardiac Na⁺/H⁺ exchanger in health and disease.心脏钠氢交换体在健康和疾病中的调节。
J Mol Cell Cardiol. 2013 Aug;61:68-76. doi: 10.1016/j.yjmcc.2013.02.007. Epub 2013 Feb 18.
2
Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.钠氢交换体1的激活足以产生诱导心肌肥大和心力衰竭的钙离子信号。
Circ Res. 2008 Oct 10;103(8):891-9. doi: 10.1161/CIRCRESAHA.108.175141. Epub 2008 Sep 5.
3
Structural and functional insights into the cardiac Na⁺/H⁺ exchanger.心脏钠/氢离子交换器的结构与功能研究进展
J Mol Cell Cardiol. 2013 Aug;61:60-7. doi: 10.1016/j.yjmcc.2012.11.019. Epub 2012 Dec 7.
4
Calmodulin-binding autoinhibitory domain controls "pH-sensing" in the Na+/H+ exchanger NHE1 through sequence-specific interaction.钙调蛋白结合自抑制结构域通过序列特异性相互作用控制钠氢交换体NHE1中的“pH感知”。
Biochemistry. 1997 Oct 21;36(42):12854-61. doi: 10.1021/bi9715472.
5
Na+/H+ exchanger 1 is regulated via its lipid-interacting domain, which functions as a molecular switch: a pharmacological approach using indolocarbazole compounds.钠氢交换蛋白 1 通过其脂质相互作用结构域进行调节,该结构域作为分子开关发挥作用:使用吲哚咔唑化合物的药理学方法。
Mol Pharmacol. 2014 Jan;85(1):18-28. doi: 10.1124/mol.113.089268. Epub 2013 Oct 17.
6
Crystal structure of CHP2 complexed with NHE1-cytosolic region and an implication for pH regulation.与NHE1胞质区域复合的CHP2的晶体结构及其对pH调节的意义。
EMBO J. 2006 Jun 7;25(11):2315-25. doi: 10.1038/sj.emboj.7601145. Epub 2006 May 18.
7
Physiological role and regulation of the Na+/H+ exchanger.钠氢交换体的生理作用与调节
Can J Physiol Pharmacol. 2006 Nov;84(11):1081-95. doi: 10.1139/y06-065.
8
Structural changes in the C-terminal regulatory region of the Na⁺/H⁺ exchanger mediate phosphorylation induced regulation.C 端调节区结构改变介导钠氢交换蛋白磷酸化调节
J Mol Cell Cardiol. 2013 Aug;61:153-63. doi: 10.1016/j.yjmcc.2013.04.007. Epub 2013 Apr 17.
9
Protein kinase B/Akt phosphorylates and inhibits the cardiac Na+/H+ exchanger NHE1.蛋白激酶B/Akt使心脏钠氢交换体NHE1磷酸化并抑制其活性。
Circ Res. 2008 Oct 10;103(8):881-90. doi: 10.1161/CIRCRESAHA.108.175877. Epub 2008 Aug 28.
10
Targeting osteopontin, the silent partner of Na+/H+ exchanger isoform 1 in cardiac remodeling.靶向骨桥蛋白,其为心脏重塑中钠/氢交换体亚型1的沉默伙伴。
J Cell Physiol. 2015 Sep;230(9):2006-18. doi: 10.1002/jcp.24958.

引用本文的文献

1
Cardiomyocyte-specific NHE1 overexpression confers protection against myocardial infarction during hyperglycemia.心肌细胞特异性NHE1过表达可在高血糖期间对心肌梗死起到保护作用。
Cardiovasc Diabetol. 2025 Apr 26;24(1):184. doi: 10.1186/s12933-025-02743-3.
2
Cardioprotection and neurobehavioral impact of swimming training in ovariectomized rats.游泳训练对去卵巢大鼠的心脏保护作用及神经行为学影响
Geroscience. 2025 Apr;47(2):2317-2334. doi: 10.1007/s11357-024-01422-7. Epub 2024 Nov 11.
3
The Remaining Conundrum of the Role of the Na/H Exchanger Isoform 1 (NHE1) in Cardiac Physiology and Pathology: Can It Be Rectified?
钠/氢交换体1型(NHE1)在心脏生理和病理中的作用所遗留的难题:能否得到解决?
Rev Cardiovasc Med. 2022 Aug 15;23(8):284. doi: 10.31083/j.rcm2308284. eCollection 2022 Aug.
4
ATP-mediated increase in H efflux from retinal Müller cells of the axolotl.三磷酸腺苷介导的蝾螈视网膜 Müller 细胞外 H efflux 的增加。
J Neurophysiol. 2024 Jan 1;131(1):124-136. doi: 10.1152/jn.00321.2023. Epub 2023 Dec 20.
5
Sodium-glucose Cotransporter 2 Inhibitors and Pathological Myocardial Hypertrophy.钠-葡萄糖协同转运蛋白 2 抑制剂与病理性心肌肥厚。
Curr Drug Targets. 2023;24(13):1009-1022. doi: 10.2174/1389450124666230907115831.
6
Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus.比较 SGLT2 抑制剂与 DPP-4 抑制剂联合二甲双胍在急性心肌梗死合并糖尿病患者中的疗效。
Cardiovasc Diabetol. 2023 Jul 22;22(1):185. doi: 10.1186/s12933-023-01914-4.
7
Na/H Exchanger 1, a Potential Therapeutic Drug Target for Cardiac Hypertrophy and Heart Failure.钠/氢交换体1,一种治疗心肌肥厚和心力衰竭的潜在药物靶点。
Pharmaceuticals (Basel). 2022 Jul 15;15(7):875. doi: 10.3390/ph15070875.
8
Regulation of proton partitioning in kinase-activating acute myeloid leukemia and its therapeutic implication.激酶激活型急性髓系白血病中质子分区的调控及其治疗意义。
Leukemia. 2022 Aug;36(8):1990-2001. doi: 10.1038/s41375-022-01606-0. Epub 2022 May 27.
9
Structural basis of autoinhibition of the human NHE3-CHP1 complex.人NHE3-CHP1复合物自身抑制的结构基础
Sci Adv. 2022 May 27;8(21):eabn3925. doi: 10.1126/sciadv.abn3925. Epub 2022 May 25.
10
Luseogliflozin inhibits high glucose-induced TGF-2 expression in mouse cardiomyocytes by suppressing NHE-1 activity.鲁格列净通过抑制钠氢交换体-1(NHE-1)活性,抑制高糖诱导的小鼠心肌细胞中转化生长因子-2(TGF-2)的表达。
J Int Med Res. 2022 May;50(5):3000605221097490. doi: 10.1177/03000605221097490.